Burleson & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $2.22M | Buy |
30,849
+2
| +0% | +$144 | 0.55% | 55 |
|
|
2022
Q3 | $2.19M | Sell |
30,847
-7
| -0% | -$498 | 0.47% | 53 |
|
|
2022
Q2 | $2.38M | Buy |
30,854
+13
| +0% | +$1K | 0.52% | 47 |
|
|
2022
Q1 | $2.25M | Buy |
30,841
+203
| +0.7% | +$14.8K | 0.36% | 61 |
|
|
2021
Q4 | $1.91M | Sell |
30,638
-227
| -0.7% | -$14.2K | 0.28% | 62 |
|
|
2021
Q3 | $1.83M | Buy |
30,865
+2
| +0% | +$118 | 0.27% | 57 |
|
|
2021
Q2 | $2.06M | Sell |
30,863
-5
| -0% | -$334 | 0.3% | 55 |
|
|
2021
Q1 | $1.95M | Buy |
30,868
+3
| +0% | +$189 | 0.32% | 53 |
|
|
2020
Q4 | $1.92M | Hold |
30,865
| – | – | 0.33% | 53 |
|
|
2020
Q3 | $1.97M | Buy |
30,865
+20
| +0.1% | +$1.28K | 0.37% | 53 |
|
|
2020
Q2 | $1.88M | Sell |
30,845
-266
| -0.9% | -$16.2K | 0.41% | 52 |
|
|
2020
Q1 | $1.9M | Buy |
31,111
+77
| +0.2% | +$4.7K | 0.49% | 51 |
|
|
2019
Q4 | $2.09M | Buy |
31,034
+450
| +1% | +$30.3K | 0.59% | 49 |
|
|
2019
Q3 | $1.68M | Buy |
30,584
+53
| +0.2% | +$2.9K | 0.58% | 46 |
|
|
2019
Q2 | $1.38M | Hold |
30,531
| – | – | 0.58% | 49 |
|
|
2019
Q1 | $1.48M | Buy |
30,531
+1,467
| +5% | +$71.3K | 0.63% | 43 |
|
|
2018
Q4 | $1.46M | Buy |
29,064
+4,947
| +21% | +$248K | 0.75% | 38 |
|
|
2018
Q3 | $1.29M | Buy |
24,117
+90
| +0.4% | +$4.81K | 0.72% | 39 |
|
|
2018
Q2 | $1.33M | Buy |
24,027
+1,047
| +5% | +$58K | 0.77% | 42 |
|
|
2018
Q1 | $1.45M | Buy |
22,980
+38
| +0.2% | +$2.4K | 0.95% | 36 |
|
|
2017
Q4 | $1.41M | Buy |
+22,942
| New | +$1.41M | 0.9% | 38 |
|